Claim being checked · Version 1 · Reviewed
“Thymosin alpha-1 is FDA-approved in the United States.”
Written and source-checked by Anthony Treviso, founder of The Peptide Field.
No dosing advice. This guide explains research. It was not independently medically reviewed, and it does not diagnose, prescribe, or recommend treatment.
Misleading. This statement leaves out a limit that changes its meaning.
Answer scope
This verdict checks the exact claim in the heading. It is not a universal grade for Thymosin alpha-1.
01 · Answer
Misleading
FDA says no approved U.S. drug contains thymosin alpha-1 free base or its acetate salt. Foreign product status does not create U.S. approval.
- What kind of evidence this is
- Regulatory or product record. This answer uses an official regulator record or a specific product label.
- What this answer covers
- United States regulatory status as reviewed August 30, 2026. This answer covers only the named molecule and finished product. It also covers the product form and how people used it. The study limits include who took part, what was used for comparison, what changed, and how long the study lasted.
- Question type
- Approval and status. Whether a specific product has an approval or another official status.
02 · Sources
Read the sources behind this answer
01FDA evaluation of thymosin alpha-1 for pharmacy compoundingU.S. Food and Drug Administration · FDA review · 2024
Supports the corrective verdict02FDA list of substances that may present compounding safety risksU.S. Food and Drug Administration · Regulatory · 2026
Supports the corrective verdict03FDA drug approvals and databasesU.S. Food and Drug Administration · Regulatory · 2026
Supports the corrective verdict
Supports the corrective verdict02FDA list of substances that may present compounding safety risksU.S. Food and Drug Administration · Regulatory · 2026
Supports the corrective verdict03FDA drug approvals and databasesU.S. Food and Drug Administration · Regulatory · 2026
Supports the corrective verdict
- Editorial review
- Internal editorial review recorded
- Source review
- Anthony Treviso · Founder and responsible editor
- Medical review status
- Not independently medically reviewed. Editorial source review does not replace medical review.